Genetic variation in the tumor necrosis factor-α promoter region and in the stress protein hsp70-2: Susceptibility and prognostic implications in breast carcinoma

Souhir Mestiri, Noureddine Bouaouina, Slim Ben Ahmed, Achraf Khedhaier, Besma Belhadj Jrad, Sami Remadi, Lotfi Chouchane

Research output: Contribution to journalArticle

111 Citations (Scopus)

Abstract

BACKGROUND. Tumor necrosis factor-α (TNF-α) and stress proteins (heat shock proteins) are determining factors in the immune response to tumor cells. The authors designated a large study to investigate the susceptibility and prognostic implications of the genetic variation in TNF-α and hsp70-2 in breast carcinoma. METHODS. The authors used the polymerase chain reaction and restriction enzyme digestion to characterize the variation of the TNF-α promoter region and that of the hsp70-2 gene in 243 unrelated Tunisian patients with breast carcinoma and 174 healthy control subjects. Associations of the clinicopathologic parameters and the genetic markers with the rates of the breast carcinoma specific overall survival and the disease free survival (DFS) were assessed using univariate and multivariate analyses. RESULTS. A highly significant association was found between TNF2 homozygous genotype and breast carcinoma (relative risk [RR], 4.44; P = 0.006). A high relative risk of breast carcinoma was found to be associated with one hsp70-2 homozygous genotype (P2/P2; RR, 7.12; P = 0.0001). The TNF2 homozygous genotype showed a significant association with reduced DFS and/or overall survival by univariate test. Conversely, P2-hsp70-2 homozygous genotype associated with increased overall survival but not with DFS. Multivariate analysis retained significance for TNF2 homozygous genotype as an independent prognostic indicator for both DFS (RR, 2.75; P = 0.01) and overall survival (RR, 4.08; P = 0.01). CONCLUSIONS. Genetic variation in TNF-α and hsp70-2 may represent not only markers for the increased risk of breast carcinoma but also may predict the clinical outcome.

Original languageEnglish
Pages (from-to)672-678
Number of pages7
JournalCancer
Volume91
Issue number4
DOIs
Publication statusPublished - 15 Feb 2001
Externally publishedYes

Fingerprint

Heat-Shock Proteins
Genetic Promoter Regions
Tumor Necrosis Factor-alpha
Breast Neoplasms
Genotype
Disease-Free Survival
Survival
Multivariate Analysis
Immunologic Factors
Genetic Markers
Digestion
Healthy Volunteers
Polymerase Chain Reaction
Enzymes
Genes
Neoplasms

Keywords

  • Breast carcinoma
  • Polymorphism
  • Prognosis
  • Stress proteins
  • Tumor necrosis factor

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Genetic variation in the tumor necrosis factor-α promoter region and in the stress protein hsp70-2 : Susceptibility and prognostic implications in breast carcinoma. / Mestiri, Souhir; Bouaouina, Noureddine; Ahmed, Slim Ben; Khedhaier, Achraf; Jrad, Besma Belhadj; Remadi, Sami; Chouchane, Lotfi.

In: Cancer, Vol. 91, No. 4, 15.02.2001, p. 672-678.

Research output: Contribution to journalArticle

Mestiri, Souhir ; Bouaouina, Noureddine ; Ahmed, Slim Ben ; Khedhaier, Achraf ; Jrad, Besma Belhadj ; Remadi, Sami ; Chouchane, Lotfi. / Genetic variation in the tumor necrosis factor-α promoter region and in the stress protein hsp70-2 : Susceptibility and prognostic implications in breast carcinoma. In: Cancer. 2001 ; Vol. 91, No. 4. pp. 672-678.
@article{f26324a467c543b9b735665e7d48449d,
title = "Genetic variation in the tumor necrosis factor-α promoter region and in the stress protein hsp70-2: Susceptibility and prognostic implications in breast carcinoma",
abstract = "BACKGROUND. Tumor necrosis factor-α (TNF-α) and stress proteins (heat shock proteins) are determining factors in the immune response to tumor cells. The authors designated a large study to investigate the susceptibility and prognostic implications of the genetic variation in TNF-α and hsp70-2 in breast carcinoma. METHODS. The authors used the polymerase chain reaction and restriction enzyme digestion to characterize the variation of the TNF-α promoter region and that of the hsp70-2 gene in 243 unrelated Tunisian patients with breast carcinoma and 174 healthy control subjects. Associations of the clinicopathologic parameters and the genetic markers with the rates of the breast carcinoma specific overall survival and the disease free survival (DFS) were assessed using univariate and multivariate analyses. RESULTS. A highly significant association was found between TNF2 homozygous genotype and breast carcinoma (relative risk [RR], 4.44; P = 0.006). A high relative risk of breast carcinoma was found to be associated with one hsp70-2 homozygous genotype (P2/P2; RR, 7.12; P = 0.0001). The TNF2 homozygous genotype showed a significant association with reduced DFS and/or overall survival by univariate test. Conversely, P2-hsp70-2 homozygous genotype associated with increased overall survival but not with DFS. Multivariate analysis retained significance for TNF2 homozygous genotype as an independent prognostic indicator for both DFS (RR, 2.75; P = 0.01) and overall survival (RR, 4.08; P = 0.01). CONCLUSIONS. Genetic variation in TNF-α and hsp70-2 may represent not only markers for the increased risk of breast carcinoma but also may predict the clinical outcome.",
keywords = "Breast carcinoma, Polymorphism, Prognosis, Stress proteins, Tumor necrosis factor",
author = "Souhir Mestiri and Noureddine Bouaouina and Ahmed, {Slim Ben} and Achraf Khedhaier and Jrad, {Besma Belhadj} and Sami Remadi and Lotfi Chouchane",
year = "2001",
month = "2",
day = "15",
doi = "10.1002/1097-0142(20010215)91:4<672::AID-CNCR1050>3.0.CO;2-J",
language = "English",
volume = "91",
pages = "672--678",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Genetic variation in the tumor necrosis factor-α promoter region and in the stress protein hsp70-2

T2 - Susceptibility and prognostic implications in breast carcinoma

AU - Mestiri, Souhir

AU - Bouaouina, Noureddine

AU - Ahmed, Slim Ben

AU - Khedhaier, Achraf

AU - Jrad, Besma Belhadj

AU - Remadi, Sami

AU - Chouchane, Lotfi

PY - 2001/2/15

Y1 - 2001/2/15

N2 - BACKGROUND. Tumor necrosis factor-α (TNF-α) and stress proteins (heat shock proteins) are determining factors in the immune response to tumor cells. The authors designated a large study to investigate the susceptibility and prognostic implications of the genetic variation in TNF-α and hsp70-2 in breast carcinoma. METHODS. The authors used the polymerase chain reaction and restriction enzyme digestion to characterize the variation of the TNF-α promoter region and that of the hsp70-2 gene in 243 unrelated Tunisian patients with breast carcinoma and 174 healthy control subjects. Associations of the clinicopathologic parameters and the genetic markers with the rates of the breast carcinoma specific overall survival and the disease free survival (DFS) were assessed using univariate and multivariate analyses. RESULTS. A highly significant association was found between TNF2 homozygous genotype and breast carcinoma (relative risk [RR], 4.44; P = 0.006). A high relative risk of breast carcinoma was found to be associated with one hsp70-2 homozygous genotype (P2/P2; RR, 7.12; P = 0.0001). The TNF2 homozygous genotype showed a significant association with reduced DFS and/or overall survival by univariate test. Conversely, P2-hsp70-2 homozygous genotype associated with increased overall survival but not with DFS. Multivariate analysis retained significance for TNF2 homozygous genotype as an independent prognostic indicator for both DFS (RR, 2.75; P = 0.01) and overall survival (RR, 4.08; P = 0.01). CONCLUSIONS. Genetic variation in TNF-α and hsp70-2 may represent not only markers for the increased risk of breast carcinoma but also may predict the clinical outcome.

AB - BACKGROUND. Tumor necrosis factor-α (TNF-α) and stress proteins (heat shock proteins) are determining factors in the immune response to tumor cells. The authors designated a large study to investigate the susceptibility and prognostic implications of the genetic variation in TNF-α and hsp70-2 in breast carcinoma. METHODS. The authors used the polymerase chain reaction and restriction enzyme digestion to characterize the variation of the TNF-α promoter region and that of the hsp70-2 gene in 243 unrelated Tunisian patients with breast carcinoma and 174 healthy control subjects. Associations of the clinicopathologic parameters and the genetic markers with the rates of the breast carcinoma specific overall survival and the disease free survival (DFS) were assessed using univariate and multivariate analyses. RESULTS. A highly significant association was found between TNF2 homozygous genotype and breast carcinoma (relative risk [RR], 4.44; P = 0.006). A high relative risk of breast carcinoma was found to be associated with one hsp70-2 homozygous genotype (P2/P2; RR, 7.12; P = 0.0001). The TNF2 homozygous genotype showed a significant association with reduced DFS and/or overall survival by univariate test. Conversely, P2-hsp70-2 homozygous genotype associated with increased overall survival but not with DFS. Multivariate analysis retained significance for TNF2 homozygous genotype as an independent prognostic indicator for both DFS (RR, 2.75; P = 0.01) and overall survival (RR, 4.08; P = 0.01). CONCLUSIONS. Genetic variation in TNF-α and hsp70-2 may represent not only markers for the increased risk of breast carcinoma but also may predict the clinical outcome.

KW - Breast carcinoma

KW - Polymorphism

KW - Prognosis

KW - Stress proteins

KW - Tumor necrosis factor

UR - http://www.scopus.com/inward/record.url?scp=0035864931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035864931&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(20010215)91:4<672::AID-CNCR1050>3.0.CO;2-J

DO - 10.1002/1097-0142(20010215)91:4<672::AID-CNCR1050>3.0.CO;2-J

M3 - Article

C2 - 11241233

AN - SCOPUS:0035864931

VL - 91

SP - 672

EP - 678

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 4

ER -